Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Evofem Biosciences Inc (NASDAQ: EVFM) Recently Executed an Agreement With VitaCare…
Vaxxinity Inc (NASDAQ: VAXX) Recently Issued an Update of Its STL…
Sorrento Therapeutics Inc (NASDAQ: SRNE) Recently Issued an Update of Its…
Allogene Therapeutics Inc (NASDAQ: ALLO) Recently Issued a Statement Following FDA’s…
Field Trip Health Ltd (NASDAQ: FTRP) Announces Board Approval To Reorganise…
Finance
Cutting Edge Power announces an all-new version of its popular Smart…
Lucid Group Inc (NASDAQ:LCID) Poised for Action as New Catalysts Mount
Galera Therapeutics Inc. (NASDAQ: GRTX) Announced Updated Findings Of Phase 3…
Pasithea Therapeutics Corp (NASDAQ: KTTA) Expands IV Ketamine Therapy Availability In…
Karyopharm Therapeutics Inc. (NASDAQ: KPTI) Doses Subjects In Study Evaluating selinexor…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:HALO
Tag: NASDAQ:HALO
Halozyme Therapeutics Inc. (NASDAQ: HALO) Announces Findings From argnex’s third phase...
Gavins Felicity
-
March 30, 2022
0
Halozyme Therapeutics Inc. (NASDAQ: HALO) Announces That Janssen Biotech Has Received...
Gavins Felicity
-
December 16, 2021
0
Halozyme Therapeutics Inc. (NASDAQ:HALO) Reports Strong Q3 With Revenue Of $65.3...
Kate Hudson
-
November 17, 2020
0
Halozyme Therapeutics, Inc. (NASDAQ:HALO) And Argenx Expand Their Partnership And License...
Kate Hudson
-
October 23, 2020
0
Halozyme Therapeutics (NASDAQ:HALO) Announce Presentation of Phase 1b Study of Atezolizumab...
Kate Hudson
-
October 2, 2020
0
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Expects To Post Revenues Of $245 Million...
Kate Hudson
-
August 27, 2020
0
Halozyme Therapeutics Inc. (NASDAQ:HALO) Announce That The EMA Has Approved Jannsen’s...
Kate Hudson
-
June 16, 2020
0
Recent Post
Top Cannabis Ideas as Pot Stocks Become Deep Value Investment Theme...
Matt Wade
-
May 19, 2022
0
The recession shade is casting a pall over the US equities market over recent weeks (1). More Wall Street houses are starting...
Value Builds in Select Crypto Mining Stocks (HIVE, BLQC, RIOT, MARA,...
May 19, 2022
Evofem Biosciences Inc (NASDAQ: EVFM) Recently Executed an Agreement With VitaCare...
May 19, 2022
Vaxxinity Inc (NASDAQ: VAXX) Recently Issued an Update of Its STL...
May 18, 2022
Sorrento Therapeutics Inc (NASDAQ: SRNE) Recently Issued an Update of Its...
May 17, 2022
Close
